GPCR - Structure Therapeutics Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 2 days)
EPS Est: $-0.47
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
3.97B
Volume:
764,090
Avg Volume:
1,537,593
52 Week Range:
13.22-94.9
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-2.16
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
163
IPO Date:
2023-02-03
EPS (TTM):
-2.34
P/E Ratio:
-11.65
Revenue (TTM):
N/A
Total Assets:
903.33M
Total Debt:
3.86M
Cash & Equiv:
169.51M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-18.2%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.37 | $-0.36 | -2.8% | — | — | — |
| 2025-08-06 | $-0.36 | $-0.28 | -28.6% | — | — | — |
| 2025-05-08 | $-0.27 | $-0.24 | -12.5% | — | — | — |
| 2025-02-27 | $-0.22 | $-0.23 | +4.3% | $1.8M | — | — |
| 2024-11-13 | $-0.20 | $-0.19 | -5.3% | — | — | — |
| 2024-08-08 | $-0.18 | $-0.23 | +21.7% | — | — | — |
| 2024-05-09 | $-0.19 | $-0.21 | +9.5% | — | — | — |
| 2024-03-08 | $-0.17 | $-0.21 | +19.0% | $1.3M | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Net Income | (122.53M) | (89.62M) | (51.32M) | (40.01M) | (15.90M) |
| EPS | -2.34 | -2.43 | -1.44 | -1.20 | -0.45 |
| Total Assets | 903.33M | 482.02M | 97.84M | 111.16M | 38.70M |
| Total Debt | 3.86M | 5.45M | 260,000 | 621,000 | 280,000 |
| Cash & Equivalents | 169.51M | 129.79M | 26.09M | 105.31M | 16.35M |
| Operating Cash Flow | (116.64M) | (79.49M) | (46.12M) | (32.16M) | (14.28M) |
| Free Cash Flow | (117.93M) | (81.66M) | (46.27M) | (33.37M) | (14.30M) |
| FCF per Share | -2.24 | -2.22 | -1.26 | -0.91 | -0.39 |
| Book Value | 864.84M | 452.97M | (115.14M) | (64.73M) | (22.47M) |
| Cash & ST Investments | 883.52M | 467.32M | 90.84M | 107.31M | 37.45M |
| ROC Equity | -0.14 | -0.20 | N/A | N/A | N/A |